Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
At the time of the <i>Therasense</i> decision there was some question as to just how stringently the Federal Circuit would adhere to the nominal standards for common law fraud. <i>Aventis Pharma S.A. v. Hospira, Inc.</i> appears to answer that question for both patent prosecutors and litigators.
Features
Highlights of the latest insurance cases from around the country.
Features
In the absence of a definition, courts have divided over whether the phrase "in your care" is ambiguous and should be read in favor of the insured and coverage, or according to its plain meaning as applied to the specific facts at issue.
Features
On April 2, 2012, Johnson Controls and certain of its excess insurers filed simultaneous motions for summary judgment on the duty to defend issue in the Milwaukee County circuit court. The outcome of these motions will be of great interest to insurers since Johnson Controls is seeking to fundamentally change the role and function of excess insurance.
Can a firm be saved when it is facing multiple critical threats to its existence? The answer is yes ' <i>if the firm acts quickly and decisively.</i>
Features
Expert analysis of important rulings.
Will courts will enforce liquidated damages clauses in real estate leases? A look at recent rulings.
Features
Analysis of recent key decisions.
